Sun Pharma Challenges US Antitrust Ruling

Indian Firm Seeks Leave To Appeal Antitrust Judgement

India’s Sun Pharma has sought leave to appeal a US court ruling rejecting the company’s bid for dismissal of a multidistrict antitrust lawsuit involving its troubled Ranbaxy subsidiary.

Appeal_Gavel
Sun is seeking to appeal the ruling • Source: Shutterstock

Sun Pharmaceutical Industries has asked a US federal judge for the right to appeal a court ruling rejecting the company’s request for dismissal of a multidistrict lawsuit alleging violation of antitrust and consumer laws.

The litigation being heard by a Boston court against Sun and its US subsidiary Ranbaxy Inc. involves five consolidated...

More from Legal & IP

More from Generics Bulletin